UK medicines agency raises fees in line with increased workload
This article was originally published in SRA
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is set to raise its fees for a number of procedures from 1 April 2009. Aimed at increasing MHRA income from fees by 3% in the forthcoming financial year, the fee revision will also see certain contributions abolished.